Royal Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.09M Sell
35,163
-32,433
-48% -$2.85M ﹤0.01% 2700
2025
Q1
$6.16M Buy
67,596
+23,491
+53% +$2.14M ﹤0.01% 1883
2024
Q4
$3.81M Buy
44,105
+1,032
+2% +$89.1K ﹤0.01% 2222
2024
Q3
$4.09M Buy
43,073
+13,222
+44% +$1.26M ﹤0.01% 2155
2024
Q2
$2.73M Buy
29,851
+5,750
+24% +$526K ﹤0.01% 2402
2024
Q1
$2.19M Sell
24,101
-3,135
-12% -$284K ﹤0.01% 2529
2023
Q4
$2.22M Buy
27,236
+4,095
+18% +$333K ﹤0.01% 2559
2023
Q3
$1.85M Sell
23,141
-31,128
-57% -$2.49M ﹤0.01% 2527
2023
Q2
$4.28M Buy
54,269
+6,027
+12% +$475K ﹤0.01% 1935
2023
Q1
$3.75M Buy
48,242
+3,920
+9% +$304K ﹤0.01% 2047
2022
Q4
$3.45M Sell
44,322
-12,061
-21% -$937K ﹤0.01% 2109
2022
Q3
$3.79M Sell
56,383
-3,351
-6% -$225K ﹤0.01% 1991
2022
Q2
$4.59M Buy
59,734
+26,114
+78% +$2.01M ﹤0.01% 1896
2022
Q1
$2.68M Buy
33,620
+4,333
+15% +$346K ﹤0.01% 2428
2021
Q4
$2.25M Buy
29,287
+14,236
+95% +$1.1M ﹤0.01% 2627
2021
Q3
$1.1M Buy
15,051
+800
+6% +$58.3K ﹤0.01% 3148
2021
Q2
$1.04M Sell
14,251
-51,755
-78% -$3.78M ﹤0.01% 3214
2021
Q1
$4.56M Buy
66,006
+41,441
+169% +$2.86M ﹤0.01% 2029
2020
Q4
$1.63M Sell
24,565
-9,557
-28% -$635K ﹤0.01% 2672
2020
Q3
$2.12M Sell
34,122
-22,108
-39% -$1.37M ﹤0.01% 2293
2020
Q2
$3.5M Buy
56,230
+37,430
+199% +$2.33M ﹤0.01% 1925
2020
Q1
$1.02M Sell
18,800
-5,338
-22% -$290K ﹤0.01% 2638
2019
Q4
$1.55M Buy
24,138
+11,110
+85% +$713K ﹤0.01% 2601
2019
Q3
$742K Sell
13,028
-39,101
-75% -$2.23M ﹤0.01% 3048
2019
Q2
$3.06M Buy
52,129
+27,907
+115% +$1.64M ﹤0.01% 2053
2019
Q1
$1.47M Buy
24,222
+6,342
+35% +$385K ﹤0.01% 2457
2018
Q4
$978K Buy
17,880
+7,897
+79% +$432K ﹤0.01% 2655
2018
Q3
$642K Buy
9,983
+75
+0.8% +$4.82K ﹤0.01% 3166
2018
Q2
$585K Sell
9,908
-2,300
-19% -$136K ﹤0.01% 3143
2018
Q1
$694K Buy
12,208
+920
+8% +$52.3K ﹤0.01% 2908
2017
Q4
$670K Sell
11,288
-1,925
-15% -$114K ﹤0.01% 2928
2017
Q3
$764K Buy
13,213
+2,203
+20% +$127K ﹤0.01% 2839
2017
Q2
$651K Buy
11,010
+792
+8% +$46.8K ﹤0.01% 2854
2017
Q1
$564K Sell
10,218
-17,680
-63% -$976K ﹤0.01% 2985
2016
Q4
$1.47M Buy
27,898
+15,943
+133% +$837K ﹤0.01% 2261
2016
Q3
$687K Sell
11,955
-1,707
-12% -$98.1K ﹤0.01% 2809
2016
Q2
$800K Sell
13,662
-2,525
-16% -$148K ﹤0.01% 2711
2016
Q1
$931K Sell
16,187
-6,267
-28% -$360K ﹤0.01% 2607
2015
Q4
$1.47M Buy
22,454
+8,323
+59% +$544K ﹤0.01% 2276
2015
Q3
$890K Buy
14,131
+665
+5% +$41.9K ﹤0.01% 2485
2015
Q2
$952K Sell
13,466
-118
-0.9% -$8.34K ﹤0.01% 2549
2015
Q1
$954K Sell
13,584
-2,724
-17% -$191K ﹤0.01% 2514
2014
Q4
$1.05M Sell
16,308
-826
-5% -$53K ﹤0.01% 2401
2014
Q3
$1.09M Sell
17,134
-6,805
-28% -$432K ﹤0.01% 2338
2014
Q2
$1.49M Buy
23,939
+11,915
+99% +$739K ﹤0.01% 2134
2014
Q1
$701K Buy
12,024
+4,149
+53% +$242K ﹤0.01% 2647
2013
Q4
$418K Sell
7,875
-3,307
-30% -$176K ﹤0.01% 3000
2013
Q3
$535K Buy
11,182
+275
+3% +$13.2K ﹤0.01% 2837
2013
Q2
$495K Buy
+10,907
New +$495K ﹤0.01% 2662